The Covid Apollo Project brings together leading life sciences investment funds with diagnostics expertise to identify, scale up, and bring to market affordable Covid-19 testing solutions at a pandemic scale. Covid Apollo has pledged $4.5 million to help fund the XPRIZE Rapid Covid Testing competition, run by XPRIZE and OpenCovidScreen. The XPRIZE Rapid Covid Testing competition will call on the world’s brightest, most innovative minds to develop new, low-cost testing solutions that range from testing devices with 15-minute results to distributed lab testing methods with “next morning” results. Frequent, fast-turnaround, easy-to-use testing enables effective data-driven tracing and isolating strategies.